SCHEMBL1190071

SCHEMBL1190071

O=C(C=Cc1ccc(CO)o1)C=Cc1ccc(CO)o1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.60
TSHR P16473 1/20 0.60
TDP1 Q9NUW8 1/20 0.46
HDAC1 Q13547 8/20 0.44
CYP2D6 P10635 3/20 0.43
CYP1A2 P05177 3/20 0.43
CYP1B1 Q16678 1/20 0.43
HDAC4 P56524 7/20 0.43
HDAC3 O15379 6/20 0.43
HDAC7 Q8WUI4 6/20 0.43
HDAC2 Q92769 6/20 0.43
HDAC10 Q969S8 6/20 0.43
HDAC11 Q96DB2 6/20 0.43
HDAC8 Q9BY41 6/20 0.43
HDAC6 Q9UBN7 6/20 0.43
HDAC9 Q9UKV0 6/20 0.43
HDAC5 Q9UQL6 6/20 0.43
MAPT P10636 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1190069 1.00 ALDH1A1 (0.60) ALDH1A1TSHRTDP1HDAC1CYP2D6
SCHEMBL25866796 0.92 CYP1A2 (0.55) ALDH1A1TSHRTDP1HDAC1CYP2D6
SCHEMBL9907020 0.88 ALDH1A1 (0.51) ALDH1A1TSHRTDP1HDAC1CYP2D6
SCHEMBL3202914 0.87 ALDH1A1 (0.58) ALDH1A1TSHRTDP1HDAC1CYP2D6
SCHEMBL3202919 0.87 ALDH1A1 (0.58) ALDH1A1TSHRTDP1HDAC1CYP2D6
SCHEMBL1189825 0.85 ALDH1A1 (0.61) ALDH1A1TSHRTDP1HDAC1CYP2D6
SCHEMBL22645114 0.85 ALDH1A1 (0.56) ALDH1A1TSHRTDP1HDAC1CYP2D6
SCHEMBL1189823 0.85 ALDH1A1 (0.61) ALDH1A1TSHRTDP1HDAC1CYP2D6
SCHEMBL1180538 0.83 CYP1A2 (0.42) ALDH1A1TSHRTDP1HDAC1CYP2D6
SCHEMBL1180535 0.83 CYP1A2 (0.42) ALDH1A1TSHRTDP1HDAC1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8507700-B2 Method of carbon chain extension using novel aldol reaction LOS ALAMOS NATIONAL SECURITY, LLC (US) 2013-08-13 US disclosed
US-20120289719-A1 Method Of Carbon Chain Extension Using Novel Aldol Reaction TRIAD NATIONAL SECURITY, LLC 2012-11-15 US disclosed
US-20110040110-A1 METHOD OF CARBON CHAIN EXTENSION USING NOVEL ALDOL REACTION LOS ALAMOS NATIONAL SECURITY, LLC (US) 2011-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110040110-A1 METHOD OF CARBON CHAIN EXTENSION USING NOVEL ALDOL REACTION AKR1C3, AKR1C2, SOD1 ALDH1A1 994/4885TSHR 3049/4885TDP1 3594/4885
US-20120289719-A1 Method Of Carbon Chain Extension Using Novel Aldol Reaction AKR1C3, AKR1C2, SOD1 ALDH1A1 1013/4885TSHR 3165/4885TDP1 3505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.